▁Chron 10.375
ic 5.49609375
▁infl 13.453125
amm 1.3642578125
ation 0.78857421875
▁in 4.1640625
▁end 6.41796875
- 3.16796875
stage 4.2578125
▁ren 6.69921875
al 0.650390625
▁disease 3.6953125
▁( 2.6796875
ES 1.4091796875
R 0.383544921875
D 3.77734375
) 0.442626953125
▁and 3.779296875
▁the 3.787109375
▁role 7.3203125
▁of 1.36328125
▁d 5.828125
ial 0.60107421875
ysis 0.2025146484375
▁are 4.5703125
▁two 3.9375
▁critical 6.21875
▁aspects 5.296875
▁discussed 7.54296875
▁in 0.9609375
▁the 1.3427734375
▁article 5.1171875
▁" 3.220703125
Chr 5.43359375
onic 0.78173828125
▁In 3.537109375
fl 0.11578369140625
amm 0.040313720703125
ation 0.019866943359375
▁in 1.03515625
▁End 0.578125
- 0.11395263671875
Stage 1.1103515625
▁Ren 0.263916015625
al 0.08782958984375
▁D 0.043731689453125
ise 0.263916015625
ase 0.01824951171875
▁and 3.638671875
▁D 0.8505859375
ial 0.01229095458984375
ysis 0.008270263671875
". 2.41015625
▁This 3.3671875
▁ess 5.30078125
ay 2.86328125
▁will 4.66796875
▁del 6.21484375
ve 1.130859375
▁into 0.5380859375
▁the 0.7509765625
▁leading 7.4296875
▁causes 5.3984375
▁of 0.74560546875
▁chron 2.169921875
ic 0.035400390625
▁infl 0.31689453125
amm 0.0212249755859375
ation 0.048583984375
▁in 0.8173828125
▁individuals 11.9609375
▁with 2.677734375
▁E 4.30859375
SR 0.1358642578125
D 2.107421875
, 2.390625
▁the 3.748046875
▁impact 6.22265625
▁of 0.9130859375
▁the 3.275390625
▁disease 6.0390625
▁on 3.939453125
▁clin 7.3359375
ical 0.233642578125
▁out 4.24609375
comes 0.130859375
, 0.78759765625
▁the 1.3916015625
▁role 3.443359375
▁of 0.2054443359375
▁middle 10.734375
▁mole 8.140625
cules 1.1923828125
▁in 1.67578125
▁its 7.23828125
▁development 6.40234375
, 0.74169921875
▁and 1.5146484375
▁the 0.5458984375
▁latest 7.6484375
▁break 5.7734375
through 0.08099365234375
s 0.6689453125
▁and 3.57421875
▁research 5.49609375
▁in 2.40625
▁d 3.423828125
ial 0.05615234375
ysis 0.01535797119140625
▁to 5.0625
▁stabil 8.5234375
ize 0.99853515625
▁the 1.953125
▁condition 5.39453125
. 1.48828125
<0x0A> 1.0712890625
The 1.80078125
▁article 2.08984375
▁highlight 5.65625
s 0.08245849609375
▁that 3.197265625
▁the 1.123046875
▁leading 4.01171875
▁causes 0.62939453125
▁of 0.08538818359375
▁chron 0.381103515625
ic 0.0011224746704101562
▁infl 0.0298309326171875
amm 0.006908416748046875
ation 0.00409698486328125
▁in 0.403564453125
▁patients 3.01171875
▁with 0.330810546875
▁E 1.2890625
SR 0.0390625
D 0.0037136077880859375
▁include 2.93359375
▁ox 6.14453125
id 0.05413818359375
ative 0.08099365234375
▁stress 0.157470703125
, 0.34765625
▁mal 5.4453125
nut 0.11029052734375
r 0.0008625984191894531
ition 0.0015420913696289062
, 0.0789794921875
▁in 2.904296875
fection 0.82275390625
, 0.09979248046875
▁and 1.2802734375
▁the 3.4921875
▁accum 5.16796875
ulation 0.0246429443359375
▁of 0.0178680419921875
▁middle 11.8046875
▁mole 0.08013916015625
cules 0.0280609130859375
. 1.12109375
▁These 3.607421875
▁factors 2.533203125
▁contribute 2.4921875
▁to 0.07391357421875
▁the 0.525390625
▁activation 7.31640625
▁of 0.11181640625
▁pro 3.109375
- 0.387939453125
infl 0.043121337890625
am 0.01088714599609375
mat 0.0006427764892578125
ory 8.821487426757812e-06
▁path 2.302734375
ways 0.00945281982421875
▁in 2.033203125
▁the 0.93798828125
▁body 1.1416015625
, 1.3896484375
▁leading 2.376953125
▁to 0.01171875
▁sust 8.609375
ained 0.0301513671875
▁infl 1.345703125
amm 0.2117919921875
ation 0.00360870361328125
. 1.3515625
▁The 1.4697265625
▁presence 6.12890625
▁of 0.017486572265625
▁chron 1.1796875
ic 0.004230499267578125
▁infl 0.07061767578125
amm 0.014678955078125
ation 0.0018157958984375
▁further 5.828125
▁ex 2.7578125
ac 0.034088134765625
erb 0.00014281272888183594
ates 0.01251220703125
▁the 0.35107421875
▁pro 2.4609375
gression 0.04656982421875
▁of 0.053192138671875
▁ren 3.306640625
al 0.00016367435455322266
▁failure 1.8564453125
, 1.5302734375
▁creating 6.25390625
▁a 0.810546875
▁v 1.2109375
icious 3.910064697265625e-05
▁cycle 0.075439453125
. 1.458984375
▁By 5.7421875
▁understanding 2.560546875
▁these 2.900390625
▁leading 1.8232421875
▁causes 0.08258056640625
, 2.041015625
▁health 3.072265625
care 0.2181396484375
▁profession 0.93212890625
als 1.3709068298339844e-05
▁can 0.276611328125
▁dev 4.0390625
ise 0.0005955696105957031
▁inter 4.28125
vent 0.08245849609375
ions 0.0265350341796875
▁to 0.54638671875
▁mit 2.55078125
ig 1.7881393432617188e-05
ate 0.00044536590576171875
▁infl 3.1953125
amm 0.1402587890625
ation 0.0015325546264648438
▁and 0.6943359375
▁potentially 5.89453125
▁improve 2.58203125
▁clin 3.5703125
ical 0.0009832382202148438
▁out 0.035858154296875
comes 8.952617645263672e-05
▁for 3.09765625
▁patients 0.52734375
▁with 0.411865234375
▁E 0.1851806640625
SR 0.0017032623291015625
D 0.0009937286376953125
. 0.10064697265625
<0x0A> 0.276611328125
ES 7.71875
R 0.0469970703125
D 0.029296875
▁has 4.0234375
▁a 1.6474609375
▁significant 1.90234375
▁impact 0.251220703125
▁on 0.0082855224609375
▁clin 3.744140625
ical 0.004848480224609375
▁out 0.084228515625
comes 9.417533874511719e-05
, 1.1630859375
▁resulting 3.892578125
▁in 0.1513671875
▁increased 2.154296875
▁mor 1.5390625
bid 0.001209259033203125
ity 0.0206756591796875
▁and 0.1461181640625
▁mort 0.0113983154296875
ality 2.968311309814453e-05
▁rates 1.3466796875
. 0.317626953125
▁The 1.646484375
▁chron 4.546875
ic 0.0107574462890625
▁infl 0.1563720703125
amm 0.07080078125
ation 0.0004470348358154297
▁associated 1.7890625
▁with 0.0007791519165039062
▁E 0.1851806640625
SR 0.0019550323486328125
D 0.00029468536376953125
▁cont 1.7294921875
ributes 2.110004425048828e-05
▁to 0.024627685546875
▁card 5.05078125
i 0.0723876953125
ov 0.005039215087890625
asc 0.00011456012725830078
ular 2.86102294921875e-06
▁comp 2.1953125
lications 0.0009398460388183594
, 0.3056640625
▁an 5.07421875
emia 0.10400390625
, 0.017181396484375
▁b 3.07421875
one 0.1729736328125
▁disease 2.640625
, 0.01230621337890625
▁and 0.339599609375
▁imm 3.626953125
un 1.7734375
ode 2.23828125
fic 0.005474090576171875
iency 0.039581298828125
, 1.9541015625
▁among 0.6796875
▁other 0.73583984375
▁comp 2.00390625
lications 0.0022373199462890625
. 0.054443359375
▁The 1.916015625
▁continuous 6.97265625
▁activation 1.767578125
▁of 0.019683837890625
▁pro 0.67822265625
- 0.0156707763671875
infl 0.0026187896728515625
am 0.0013027191162109375
mat 0.00018513202667236328
ory 1.4662742614746094e-05
▁path 0.07275390625
ways 0.0003848075866699219
▁places 8.1328125
▁additional 3.521484375
▁stress 0.99951171875
▁on 0.01422882080078125
▁the 0.2156982421875
▁patients 6.1328125
' 0.3828125
▁card 2.921875
i 0.07135009765625
ov 0.0014057159423828125
asc 0.0003037452697753906
ular 7.867813110351562e-06
▁system 0.693359375
, 0.60498046875
▁leading 1.8017578125
▁to 0.0005636215209960938
▁an 2.255859375
▁increased 0.2939453125
▁risk 0.08502197265625
▁of 0.05706787109375
▁heart 1.8359375
▁disease 2.453125
▁and 0.80078125
▁stroke 0.440673828125
. 0.066650390625
▁Additionally 1.5009765625
, 0.0002168416976928711
▁mal 3.59765625
function 8.1640625
ing 0.20947265625
▁kid 1.53125
ne 0.17724609375
ys 1.4901161193847656e-05
▁result 3.162109375
▁in 0.0303802490234375
▁decre 3.3046875
ased 0.00858306884765625
▁production 2.96484375
▁of 0.01496124267578125
▁er 3.48046875
yth 0.00244903564453125
ro 9.882450103759766e-05
po 0.188232421875
iet 0.021026611328125
in 0.01471710205078125
, 0.3984375
▁leading 2.8828125
▁to 0.0018548965454101562
▁an 1.33984375
emia 0.1103515625
. 0.96240234375
▁B 5.54296875
one 0.0452880859375
▁health 4.78515625
▁is 0.57080078125
▁also 0.5244140625
▁comprom 1.3994140625
ised 0.00012028217315673828
▁due 2.173828125
▁to 0.0010671615600585938
▁an 4.08203125
▁im 3.44921875
bal 0.0008225440979003906
ance 0.1165771484375
▁in 0.634765625
▁min 3.5234375
eral 0.32177734375
▁met 1.4375
abol 0.00014591217041015625
ism 0.007511138916015625
, 0.79541015625
▁resulting 1.443359375
▁in 0.01337432861328125
▁kid 7.23828125
ney 0.0084991455078125
▁o 3.634765625
ste 0.0174560546875
od 1.2353515625
yst 0.0173492431640625
ro 0.0045166015625
phy 0.00038552284240722656
. 0.317138671875
▁Under 7.58203125
standing 0.019195556640625
▁the 0.2230224609375
▁impact 3.345703125
▁of 0.047637939453125
▁E 1.767578125
SR 0.002124786376953125
D 0.0008873939514160156
▁on 0.1759033203125
▁clin 0.31640625
ical 0.0002090930938720703
▁out 0.00850677490234375
comes 2.09808349609375e-05
▁emphas 9.96875
izes 0.007091522216796875
▁the 0.01363372802734375
▁ur 4.74609375
gency 1.3037109375
▁in 4.25
▁developing 0.8173828125
▁effective 2.171875
▁inter 0.95458984375
vent 0.0180816650390625
ions 0.0009851455688476562
▁to 0.2183837890625
▁manage 3.412109375
▁chron 1.71875
ic 0.0006814002990722656
▁infl 0.016571044921875
amm 0.0053253173828125
ation 0.00011563301086425781
. 1.1298828125
<0x0A> 0.179931640625
Middle 7.0859375
▁mole 0.1820068359375
cules 0.0599365234375
▁have 3.0625
▁been 1.2158203125
▁identified 1.37109375
▁as 0.08026123046875
▁significant 4.5
▁contrib 0.5556640625
utors 0.045013427734375
▁to 0.035247802734375
▁the 0.82763671875
▁development 0.99609375
▁of 0.1136474609375
▁path 8.3125
ology 2.279296875
▁in 0.468017578125
▁E 1.2490234375
SR 0.005496978759765625
D 0.0013751983642578125
. 0.73095703125
▁These 1.25
▁mole 0.2132568359375
cules 0.006114959716796875
▁are 1.3525390625
▁intermediate 7.76953125
▁in 1.416015625
▁size 3.50390625
▁between 0.91357421875
▁small 3.56640625
▁and 1.5302734375
▁large 0.037750244140625
▁sol 6.46484375
utes 0.438232421875
, 0.58642578125
▁making 3.34765625
▁them 0.04315185546875
▁difficult 1.357421875
▁to 0.11395263671875
▁be 4.453125
▁effectively 4.4375
▁removed 0.98779296875
▁by 1.1982421875
▁conventional 3.720703125
▁d 0.93212890625
ial 5.042552947998047e-05
ysis 0.049468994140625
▁methods 2.41796875
. 0.0380859375
▁The 1.6796875
▁persistent 6.390625
▁accum 0.9638671875
ulation 0.0009737014770507812
▁of 0.01515960693359375
▁middle 0.8466796875
▁mole 0.0008172988891601562
cules 0.002170562744140625
▁in 1.0029296875
▁the 0.348388671875
▁body 0.81494140625
▁triggers 5.33203125
▁an 2.03515625
▁imm 1.8603515625
une 0.1793212890625
▁response 0.1055908203125
, 0.68603515625
▁leading 0.73583984375
▁to 0.0005197525024414062
▁infl 2.21875
amm 0.194580078125
ation 0.0005512237548828125
. 1.5341796875
▁Furthermore 4.08203125
, 0.00019240379333496094
▁middle 2.322265625
▁mole 0.0005941390991210938
cules 0.01071929931640625
▁can 1.748046875
▁inf 7.6640625
lict 0.57177734375
▁ox 3.80859375
id 0.00029754638671875
ative 0.00151824951171875
▁stress 0.384033203125
▁on 0.580078125
▁cells 2.24609375
▁and 1.7021484375
▁comprom 5.41796875
ise 0.0017004013061523438
▁the 1.0576171875
▁integrity 1.7138671875
▁of 0.0031299591064453125
▁end 4.875
oth 0.037506103515625
el 0.00472259521484375
ial 0.033294677734375
▁function 4.44921875
, 1.142578125
▁thereby 3.384765625
▁ex 1.875
ac 0.01068115234375
erb 0.00023925304412841797
ating 0.00022983551025390625
▁the 0.56494140625
▁path 3.30078125
ology 0.5341796875
. 1.494140625
▁Target 7.05078125
ing 0.15771484375
▁middle 0.69189453125
▁mole 0.0006055831909179688
cules 0.023468017578125
▁and 2.705078125
▁developing 3.919921875
▁better 5.6328125
▁d 1.056640625
ial 0.00510406494140625
ysis 0.060333251953125
▁techniques 1.7080078125
▁to 1.3251953125
▁eliminate 2.705078125
▁them 0.341552734375
▁can 1.9599609375
▁potentially 2.58984375
▁reduce 1.6025390625
▁chron 4.71875
ic 0.0010356903076171875
▁infl 0.00907135009765625
amm 0.00498199462890625
ation 0.00018990039825439453
▁in 1.3466796875
▁patients 0.89111328125
▁with 0.02044677734375
▁E 0.006320953369140625
SR 0.0004699230194091797
D 0.0003535747528076172
. 0.318603515625
<0x0A> 0.1009521484375
Rec 6.85546875
ent 0.259521484375
▁break 4.4765625
through 0.001010894775390625
s 0.03460693359375
▁and 1.9111328125
▁research 0.389404296875
▁in 0.49462890625
▁d 0.24365234375
ial 0.00042724609375
ysis 0.0017576217651367188
▁aim 6.2890625
▁to 0.1029052734375
▁stabil 5.49609375
ize 0.004657745361328125
▁the 0.68505859375
▁condition 0.2587890625
▁of 1.6416015625
▁individuals 2.572265625
▁with 0.07525634765625
▁E 0.09210205078125
SR 0.002597808837890625
D 0.0009622573852539062
. 1.005859375
▁The 1.4990234375
▁development 1.9443359375
▁of 0.0197296142578125
▁high 4.98828125
- 0.0966796875
fl 2.615234375
ux 0.0036411285400390625
▁d 0.68896484375
ial 0.00037097930908203125
ysis 0.2283935546875
▁memb 1.2802734375
ran 0.0631103515625
es 1.919269561767578e-05
▁enables 4.0390625
▁en 6.6015625
hanced 0.0276947021484375
▁removal 2.0703125
▁of 0.0193939208984375
▁middle 0.28076171875
▁mole 0.0018253326416015625
cules 0.0028247833251953125
, 1.369140625
▁thereby 1.9111328125
▁potentially 6.21875
▁reducing 0.51953125
▁chron 1.064453125
ic 0.000102996826171875
▁infl 0.0019044876098632812
amm 0.0016155242919921875
ation 5.936622619628906e-05
. 0.576171875
▁Additionally 1.9833984375
, 0.00011706352233886719
▁the 1.16796875
▁use 0.95556640625
▁of 0.0006275177001953125
▁con 9.3515625
ve 0.5546875
ct 0.277587890625
ive 0.00443267822265625
▁ther 4.26953125
ap 1.6005859375
ies 0.0003333091735839844
▁like 4.0625
▁hem 4.7890625
odia 2.9765625
fil 0.001926422119140625
tr 0.0004715919494628906
ation 0.0002601146697998047
▁has 3.361328125
▁shown 2.67578125
▁prom 1.6513671875
ising 9.85860824584961e-05
▁results 0.139404296875
▁in 0.2318115234375
▁reducing 1.0986328125
▁infl 2.28515625
amm 0.0968017578125
ation 0.0003159046173095703
▁by 4.32421875
▁more 7.2265625
▁effectively 0.50830078125
▁clear 4.92578125
ing 0.0007443428039550781
▁infl 7.95703125
am 0.11669921875
mat 0.00021910667419433594
ory 3.707408905029297e-05
▁medi 0.83984375
ators 0.0024871826171875
. 1.0322265625
▁Research 5.859375
ers 0.69677734375
▁are 0.2425537109375
▁also 0.6142578125
▁expl 0.76611328125
oring 2.3126602172851562e-05
▁innov 5.2421875
ative 0.007724761962890625
▁approaches 2.30078125
▁such 1.9150390625
▁as 0.0006785392761230469
▁bio 4.33203125
engine 2.3984375
ered 0.408203125
▁kid 2.279296875
ne 0.30517578125
ys 0.00013065338134765625
▁and 0.82080078125
▁reg 4.046875
ener 0.0033092498779296875
ative 0.0295562744140625
▁medicine 0.242431640625
▁to 0.8232421875
▁replace 3.595703125
▁or 2.896484375
▁repair 0.7685546875
▁dam 0.9912109375
aged 0.00017881393432617188
▁kid 0.23046875
ne 0.134765625
ys 5.9604644775390625e-06
, 1.505859375
▁offering 5.3671875
▁a 1.3583984375
▁potential 1.427734375
▁c 1.43359375
ure 0.00015592575073242188
▁for 0.191162109375
▁E 0.74267578125
SR 0.0009927749633789062
D 0.0003235340118408203
. 0.1566162109375
<0x0A> 0.87890625
In 3.17578125
▁conclusion 0.7548828125
, 0.0010156631469726562
▁chron 1.4599609375
ic 0.002696990966796875
▁infl 0.0015211105346679688
amm 0.0032520294189453125
ation 8.952617645263672e-05
▁in 1.412109375
▁E 1.6552734375
SR 0.0008931159973144531
D 0.0004322528839111328
▁is 1.17578125
▁a 0.48291015625
▁complex 2.322265625
▁phenomen 2.064453125
on 5.1140785217285156e-05
▁influenced 5.96484375
▁by 0.0027561187744140625
▁various 2.673828125
▁factors 0.1298828125
. 1.2734375
▁It 2.994140625
▁significantly 6.37109375
▁impact 1.048828125
s 0.00046539306640625
▁clin 0.326416015625
ical 8.368492126464844e-05
▁out 0.01490020751953125
comes 1.71661376953125e-05
, 0.806640625
▁leading 0.86962890625
▁to 0.0022983551025390625
▁card 4.85546875
i 0.0091552734375
ov 0.002605438232421875
asc 4.208087921142578e-05
ular 3.2186508178710938e-06
▁comp 0.548828125
lications 0.0008549690246582031
, 0.08941650390625
▁an 0.12548828125
emia 0.002620697021484375
, 0.0031147003173828125
▁b 0.07830810546875
one 0.00029015541076660156
▁disease 0.0112152099609375
, 0.011322021484375
▁and 0.09649658203125
▁imm 0.010833740234375
un 0.0182037353515625
ode 0.0024852752685546875
fic 0.0020389556884765625
iency 0.0019426345825195312
. 0.85888671875
▁Middle 3.416015625
▁mole 0.0011739730834960938
cules 0.0025234222412109375
▁play 2.244140625
▁a 0.252197265625
▁p 3.533203125
iv 5.364418029785156e-06
otal 6.9141387939453125e-06
▁role 0.0009484291076660156
▁in 0.00649261474609375
▁the 0.40576171875
▁development 0.369140625
▁of 0.061004638671875
▁path 1.66796875
ology 0.0117340087890625
, 2.310546875
▁ex 3.708984375
ac 0.00725555419921875
erb 4.7087669372558594e-05
ating 0.0059967041015625
▁chron 0.8330078125
ic 9.655952453613281e-05
▁infl 0.0004699230194091797
amm 0.0015878677368164062
ation 2.5987625122070312e-05
. 1.1533203125
▁However 4.72265625
, 0.0003578662872314453
▁recent 0.1883544921875
▁break 0.272216796875
through 0.00019550323486328125
s 0.0012426376342773438
▁and 0.2257080078125
▁research 0.0183563232421875
▁in 0.2177734375
▁d 0.00579833984375
ial 1.5735626220703125e-05
ysis 0.0004515647888183594
▁hold 9.125
▁promise 0.673828125
▁for 1.42578125
▁stabil 1.703125
izing 0.035308837890625
▁the 0.21337890625
▁condition 0.055145263671875
, 4.11328125
▁including 5.0859375
▁the 0.483154296875
▁development 0.416748046875
▁of 0.00635528564453125
▁high 0.2431640625
- 0.002941131591796875
fl 0.0037899017333984375
ux 1.7404556274414062e-05
▁memb 1.8359375
ran 0.07342529296875
es 4.839897155761719e-05
, 0.9033203125
▁con 0.42822265625
ve 0.0002942085266113281
ct 0.00499725341796875
ive 0.0005717277526855469
▁ther 0.011810302734375
ap 0.03759765625
ies 1.990795135498047e-05
, 0.1451416015625
▁and 1.0908203125
▁reg 3.33203125
ener 7.963180541992188e-05
ative 0.0019502639770507812
▁medicine 0.06365966796875
. 0.447021484375
▁By 1.306640625
▁understanding 0.257568359375
▁the 0.181396484375
▁causes 4.625
, 3.1484375
▁consequences 2.587890625
, 0.01529693603515625
▁and 0.02850341796875
▁potential 1.7529296875
▁solutions 1.3251953125
, 1.802734375
▁health 0.1357421875
care 0.01995849609375
▁profession 0.07373046875
als 1.6689300537109375e-06
▁can 0.053253173828125
▁improve 3.69921875
▁the 1.3759765625
▁management 3.341796875
▁of 0.1390380859375
▁chron 1.4794921875
ic 0.0003058910369873047
▁infl 0.004016876220703125
amm 0.0030422210693359375
ation 0.00010633468627929688
▁in 0.1680908203125
▁individuals 1.455078125
▁with 0.005374908447265625
▁E 0.0034656524658203125
SR 0.00014853477478027344
D 0.00018155574798583984
, 2.53125
▁ultimately 2.470703125
▁impro 0.9619140625
ving 1.6450881958007812e-05
▁clin 0.356689453125
ical 0.0001004934310913086
▁out 0.004180908203125
comes 2.276897430419922e-05
▁and 1.1123046875
▁en 4.546875
han 0.252685546875
cing 1.1920928955078125e-06
▁patients 2.42578125
' 0.003509521484375
▁quality 0.0872802734375
▁of 0.00348663330078125
▁life 0.0022106170654296875
. 0.004177093505859375
